Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

PURPOSE: Trastuzumab and chemotherapy is the current standard of care in HER2+ early or locally advanced breast cancer, but there are scanty literature data of its real world effectiveness. METHODS: We retrospectively reviewed 205 patients with HER2+ breast cancer diagnosed in 10 Italian Medical Onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Natoli, Clara, Vici, Patrizia, Sperduti, Isabella, Grassadonia, Antonino, Bisagni, Giancarlo, Tinari, Nicola, Michelotti, Andrea, Zampa, Germano, Gori, Stefania, Moscetti, Luca, De Tursi, Michele, Panebianco, Michele, Mauri, Maria, Ferrarini, Ilaria, Pizzuti, Laura, Ficorella, Corrado, Samaritani, Riccardo, Mentuccia, Lucia, Iacobelli, Stefano, Gamucci, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678021/
https://www.ncbi.nlm.nih.gov/pubmed/23604446
http://dx.doi.org/10.1007/s00432-013-1436-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678021/
https://www.ncbi.nlm.nih.gov/pubmed/23604446
http://dx.doi.org/10.1007/s00432-013-1436-y

Ejemplares similares